Arrowstreet Capital
TECH icon

Arrowstreet Capital’s Bio-Techne TECH Stock Holding History

Arrowstreet Capital’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.4M Sell
246,072
-120,800
-33% -$6.52M 0.01% 909
2026
Q1 		$19.2M Buy
+366,872
New +$22M 0.01% 761
2025
Q4 		– Sell
-1,135,896
Closed -$63.2M – 2024
2025
Q3 		$63.2M Buy
1,135,896
+767,821
+209% +$41.1M 0.04% 391
2025
Q2 		$18.9M Buy
368,075
+311,610
+552% +$15.7M 0.01% 704
2025
Q1 		$3.31M Buy
56,465
+1,765
+3% +$120K ﹤0.01% 1140
2024
Q4 		$3.94M Buy
+54,700
New +$4.02M ﹤0.01% 1071
2023
Q1 		– Sell
-93,451
Closed -$7.75M – 1523
2022
Q4 		$7.75M Sell
93,451
-32,505
-26% -$2.58M 0.01% 581
2022
Q3 		$8.94M Buy
125,956
+75,308
+149% +$6.51M 0.01% 545
2022
Q2 		$4.39M Buy
+50,648
New +$4.75M 0.01% 632
2022
Q1 		– Sell
-107,732
Closed -$13.9M – 1522
2021
Q4 		$13.9M Sell
107,732
-16,668
-13% -$2.04M 0.02% 569
2021
Q3 		$15.1M Buy
124,400
+102,400
+465% +$12.5M 0.02% 608
2021
Q2 		$2.48M Buy
+22,000
New +$2.32M ﹤0.01% 1288
2021
Q1 		– Sell
-286,180
Closed -$22.7M – 2528
2020
Q4 		$22.7M Sell
286,180
-99,148
-26% -$7.18M 0.03% 548
2020
Q3 		$23.9M Buy
385,328
+218,400
+131% +$14.2M 0.04% 480
2020
Q2 		$11M Buy
+166,928
New +$10M 0.02% 739
2019
Q3 		– Sell
-10,400
Closed -$542K – 1711
2019
Q2 		$542K Buy
+10,400
New +$524K ﹤0.01% 1168
2018
Q3 		– Sell
-286,400
Closed -$10.6M – 1251
2018
Q2 		$10.6M Buy
286,400
+274,400
+2,287% +$10.5M 0.03% 407
2018
Q1 		$453K Buy
+12,000
New +$424K ﹤0.01% 966
2016
Q4 		– Sell
-209,460
Closed -$5.73M – 2442
2016
Q3 		$5.73M Buy
+209,460
New +$5.75M 0.02% 610
2013
Q4 		– Sell
-5,744
Closed -$115K – 1286
2013
Q3 		$115K Buy
+5,744
New +$109K ﹤0.01% 955

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Arrowstreet Capital's TECH Position: Q2 2026 in Review

Arrowstreet Capital reduced its Bio-Techne (TECH) stake by 33% in Q2 2026, selling an estimated $6.52M and leaving 246,072 shares worth $17.4M. The position accounts for 0.01% of the portfolio, ranked #909.

Arrowstreet Capital first reported a position in TECH in Q3 2013 and has held it in 20 quarters since. The position peaked at $63.2M in Q3 2025. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Arrowstreet Capital held 246,072 shares of Bio-Techne worth $17.4M as of Q2 2026.
  • Arrowstreet Capital sold 120,800 Bio-Techne shares in Q2 2026, an estimated $6.52M.
  • Bio-Techne made up 0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #909 holding.
  • Arrowstreet Capital first reported a position in Bio-Techne in Q3 2013 and has held it in 20 quarters since.
  • Arrowstreet Capital's Bio-Techne position peaked at $63.2M in Q3 2025.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.